 - Haematological malignancy associated with human immunodeficiency virus HIV infection or solid organ transplant or history of known Hepatitis B Antigen or positive Hepatitis C antibody confirmed by Recombinant ImmunoBlot Assay RIBA, if available or alternately confirmed by Hepatitis C Virus HCV Ribonucleic acid RNA. 